4 followers
RT @CancerPapers: The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory… https://t.co/Vru…
RT @CancerPapers: The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory… https://t.co/Vru…
RT @CancerPapers: The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory… https://t.co/Vru…
The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory… https://t.co/VruZLQdJWB #leukemia https://t.co/EQCLw5Xlxc
The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric… https://t.co/Gba1tzpARj https://t.co/DZBp8I7MvK